Novel DNA vaccine design improves chances of inducing anti-tumour immunity
Scientists have devised a novel DNA vaccine approach through molecular design to improve the immune…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
PI3K/mTOR inhibitors may be effective against some uterine sarcomas
The protein P-S6S240 may serve as an indicator of poor prognosis for patients with a…
Statins do not benefit patients with lung cancer
Cholesterol-lowering drugs used alongside chemotherapy have no effect on treatment outcomes for lung cancer patients,…
Tumour protein could hold key to pancreatic cancer survival
A diagnosis of pancreatic cancer is often a death sentence because current chemotherapies have little…
Regular CA125 testing may help detect ovarian cancer in high-risk women
The combined results of two ovarian cancer screening trials suggest that a personalised strategy involving…
Colorectal cancer rates have risen dramatically in Gen X and millennials
A new study finds that compared to people born around 1950, when colorectal cancer risk…
Delays and confusion cloud roll-out of new cervical cancer screening program
Jane Williams, University of Sydney and Sally Wortley, University of Sydney Australia’s new national cervical…
How rare disease research is changing cancer treatment
Elaine Dunlop, Cardiff University Researching rare diseases and treatments can be a challenging task –…
Biomarker for lung cancer detected in the nasal passages of smokers
A new nasal test may allow patients suspected of having lung cancer to undergo a…
New test distinguishes ‘tigers’ from ‘pussycats’ in prostate cancer
A new test has been developed to make the vital distinction between aggressive and less…